Keurig Dr Pepper Inc.'s SEC filings document operating results, governance, material events, and capital-structure matters for its beverage and coffee businesses. Form 8-K reports include quarterly and full-year financial results, outlook updates, material agreements, completed acquisition-related events, and other current-report disclosures tied to the company's refreshment beverage portfolio and Keurig coffee platform.
Proxy filings describe shareholder voting matters, board governance, executive compensation, and annual meeting proposals. The filing record also covers security-structure and capital disclosures, risk and financial reporting topics, and governance changes relevant to a public operating company with owned, licensed, and partner beverage and coffee brands.
Keurig Dr Pepper Inc. (KDP) announced that its Board named Russ Torres Chief Executive Officer of the future Global Coffee Co., effective November 3, 2026. Torres will join KDP that day as CEO of its Coffee Operating Unit and lead the integration of KDP’s and JDE Peet’s coffee operations before the separation. He joins from Kimberly-Clark Corporation, where he is President and Chief Operating Officer overseeing operations in more than 30 countries.
Torres will report to KDP CEO Tim Cofer, who will become CEO of Beverage Co. following the planned separation, targeted for early 2027. Upon separation, Torres will serve on the Global Coffee Co. Board of Directors.
Keurig Dr Pepper Inc. subsidiaries DPS Holdings Inc. and Mott’s LLP, along with certain other company affiliates, completed transactions with FHU US Holdings, LLC and its affiliates, collectively Chobani, on September 28, 2026. The transactions included the redemption of all of Keurig Dr Pepper’s indirect equity interests in Chobani for $800 million in aggregate consideration.
The redemption consideration consisted of $400 million in cash and a $400 million promissory note issued by Chobani to a Keurig Dr Pepper subsidiary; the note matures on December 26, 2026. The transactions also included the sale of certain assets, including leasehold interests in two facilities in Allentown, Pennsylvania, for $125 million in cash.
Keurig Dr Pepper Inc. (symbol: KDP) is the issuer of record for a Form 4 filing submitted to the SEC. Alt Aaron E reported acquisition or exercise transactions in this Form 4 filing.
Keurig Dr Pepper Inc. (KDP) reported that director Aaron E. Alt received a grant of 2,752 restricted stock units on September 16, 2026. These units relate to the company’s common stock and are held as direct ownership.
According to the grant terms, the 2,752 restricted stock units vest on September 16, 2031, subject to specified vesting conditions and exceptions. Each unit represents a contingent right to receive one share of Keurig Dr Pepper common stock upon vesting, so the director will hold 2,752 shares if all units vest.
Keurig Dr Pepper Inc. (symbol: KDP) is the issuer of record for a Form 4 filing submitted to the SEC. DRISCOLL BRIAN J reported acquisition or exercise transactions in this Form 4 filing.
Keurig Dr Pepper Inc. (KDP) reported that director Brian J. Driscoll received a grant of 2,752 Restricted Stock Units on September 16, 2026. These RSUs are held directly and represent a contingent right to receive an equal number of shares of Keurig Dr Pepper common stock upon vesting.
The RSUs are subject to vesting conditions and, except for certain specified exceptions, are scheduled to vest on September 16, 2031. Following this grant, Driscoll holds 2,752 RSUs tied to Keurig Dr Pepper common stock.
Keurig Dr Pepper Inc. (KDP) reported that Eric Gorli, President, US Refreshment Beverages, had 3,317 restricted stock units vest and convert into common stock on September 14, 2026 under the issuer's Ombinus Stock Incentive Plan of 2026. Of the vested shares, 1,306 common shares were withheld to pay applicable taxes, and 3,316 RSUs remain outstanding after the transaction. No Rule 10b5-1 trading plan is reported.
Keurig Dr Pepper Inc. (KDP) reported that Chief Legal Officer Anthony Shoemaker had previously granted restricted stock units vest and convert into common stock on September 14, 2026. 59,781 Matching RSUs from the Elite Investment Program and 785 additional RSUs converted into common stock on a one-for-one basis under the company’s Omnibus Stock Incentive Plan.
On the same date, 23,833 common shares were withheld at $31.58 per share to pay applicable taxes upon RSU vesting in accordance with Rule 16b-3. No Rule 10b5-1 trading plan is reported for these transactions.
Keurig Dr Pepper Inc. (KDP) director Debra A. Sandler reported the vesting and conversion of previously granted equity awards on September 14, 2026. A total of 2,285 restricted stock units were exercised and converted on a one-for-one basis into 2,285 shares of common stock under the issuer’s Omnibus Stock Incentive Plan of 2026. Following the transactions, she holds 2,285 common shares directly and no remaining RSUs from this 2021 grant, and no Rule 10b5-1 trading plan is reported for these transactions.
Keurig Dr Pepper Inc. (KDP) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.23 per share, payable in U.S. dollars, on its common stock. The dividend will be paid on October 9, 2026 to shareholders of record as of September 28, 2026. This reflects the company’s ongoing practice of returning cash to shareholders through regular dividends.
Keurig Dr Pepper Inc. (KDP) reported that Chief Human Resources Officer Mary Beth DeNooyer sold a total of 24,000 shares of common stock in two open-market transactions. On September 8, 2026, she sold 12,000 shares at a weighted average price of $32.55, and on September 9, 2026, she sold 12,000 shares at a weighted average price of $32.30, each across multiple trades within disclosed price ranges. No post-transaction share balance is reported in this filing, and no Rule 10b5-1 trading plan is indicated.
Keurig Dr Pepper Inc. (KDP) received a notice that officer Mary Beth DeNooyer intends to sell shares of the company’s common stock under Rule 144. The planned sale covers 24,000 shares of common stock through J.P. Morgan Securities LLC on or after September 8, 2026, on NASDAQ.
The filing lists how these shares were acquired, including an open-market purchase on November 5, 2019, and multiple executive compensation grants between March 2, 2025, and March 3, 2026.